Citation Impact
Citing Papers
Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.
2013
Obesity Stigma: Important Considerations for Public Health
2010 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection
2014
International Diabetes Federation: a consensus on Type 2 diabetes prevention
2007
Critical review: vegetables and fruit in the prevention of chronic diseases
2012 Standout
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
The Epidemiology of Obesity: A Big Picture
2014 Standout
A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions: PRISMS – Practical systematic RevIew of Self-Management Support for long-term conditions
2014 Standout
Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database
2013 Standout
The Stigma of Obesity: A Review and Update
2009 Standout
The Case for Using Albuminuria in Staging Chronic Kidney Disease
2009
The Predicted Effects of Chronic Obesity in Middle Age on Medicare Costs and Mortality
2010
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Wearable biosensors for healthcare monitoring
2019 Standout
Screening for Chronic Kidney Disease
2008
A 4-year, cluster-randomized, controlled childhood obesity prevention study: STOPP
2009
Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison
2007
The COVID-19 pandemic: Impacts on cities and major lessons for urban planning, design, and management
2020 Standout
A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening
2010
Chronic kidney disease
2011 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
The Lifetime Medical Cost Burden of Overweight and Obesity: Implications for Obesity Prevention
2008
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Mobile Applications for Control and Self Management of Diabetes: A Systematic Review
2016 Standout
Remogliflozin etabonate, a selective inhibitor of the sodium‐dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients
2011
Chronic kidney disease: global dimension and perspectives
2013 Standout
Impact of Peer Nutrition Education on Dietary Behaviors and Health Outcomes among Latinos: A Systematic Literature Review
2008
Comparative effectiveness of telemedicine strategies on type 2 diabetes management: A systematic review and network meta-analysis
2017
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
2017 Standout
Systematic Review and Meta-analysis
2008 Standout
Evaluation of Self Monitoring of Blood Glucose in Non-Insulin-Treated Diabetic Patients by Randomized Controlled Trials: Little Bang for the Buck
2010
Screening, Monitoring, and Treatment of Albuminuria
2006
Weighing obesity stigma: the relative strength of different forms of bias
2008 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Stigma, obesity, and the health of the nation's children.
2007
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Type 2 diabetes mellitus
2015 Standout
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
2006
Cost Effectiveness of Insulin Glargine plus Oral Antidiabetes Drugs Compared with Premixed Insulin Alone in Patients with Type 2 Diabetes Mellitus in Canada
2010
End-to-end design of wearable sensors
2022 Standout
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA
2007
The economic burden of child maltreatment in the United States and implications for prevention
2012 Standout
The Impact of Body Weight on Patient Utilities with or without Type 2 Diabetes: A Review of the Medical Literature
2007
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
Improving responsiveness of health systems to non-communicable diseases
2013
Valuation of air pollution externalities: comparative assessment of economic damage and emission reduction under COVID-19 lockdown
2020
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
2016
Evaluating the cost‐effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK
2012
PRIMARY PREVENTION OF DIABETES: What Can Be Done and How Much Can Be Prevented?
2004
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis
2010
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study
2006
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2009 Standout
Lost in publication: Half of all renal practice evidence is published in non-renal journals
2006
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes
2006
Association Between Physician Volume and Hospitalization Costs for Patients With Stroke in Taiwan
2007
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Combination therapy with GLP ‐1 receptor agonists and basal insulin: a systematic review of the literature
2012
Guidelines for the Primary Prevention of Stroke
2014 Standout
Economic Evaluation of Quality Improvement Interventions Designed to Improve Glycemic Control in Diabetes: A Systematic Review and Weighted Regression Analysis
2018
Interventions for preventing obesity in children
2019 Standout
Diabetes Epidemiology: Guiding Clinical and Public Health Practice
2007
A thermal activated and differential self-calibrated flexible epidermal biomicrofluidic device for wearable accurate blood glucose monitoring
2021
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Lifetime Direct Medical Costs of Childhood Obesity
2014
Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
2010
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation
2010
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2010
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Heavy Drinking Is Associated with Poor Blood Pressure Control in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
2011
Surgery for weight loss in adults
2014 Standout
Stigma as a Fundamental Cause of Population Health Inequalities
2013 Standout
Self-monitoring of blood glucose in type 2 diabetes: systematic review
2010
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
GLP-1 receptor agonists today
2011
Works of Stéphane Roze being referenced
The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making
2004
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy
2003
Counting the costs of overweight and obesity: modeling clinical and cost outcomes
2006
Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom
2004
<p>Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program</p>
2019
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria
2004
Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus
2007
Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials
2004
Cost‐Effectiveness of Diabetes Case Management for Low‐Income Populations
2007
What Impact Would Pancreatic Beta-cell Preservation Have on Life Expectancy, Quality-adjusted Life Expectancy and Costs of Complications in Patients with Type 2 Diabetes? A Projection Using the CORE Diabetes Model
2004
Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries
2004
Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting
2005
Impact of Changes in HbA1c, Lipids and Blood Pressure on Long-term Outcomes in Type 2 Diabetes Patients: An Analysis Using the CORE Diabetes Model
2004
Cost-effectiveness of basal insulin from a US health system perspective: Comparative analyses of detemir, glargine, and NPH
2006
Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis
2007
Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies
2005
Deleterious Effects of Increased Body Weight Associated with Intensive Insulin Therapy for Type 1 Diabetes: Increased Blood Pressure and Worsened Lipid Profile Partially Negate Improvements in Life Expectancy
2004
Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes
2019
Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease
2004
Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective
2015